Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling

Fig. 3

Protein abundance of cell type-specific markers and cellular admixture analyses (xCell [21]). A Boxplots depicting relative protein abundances of classical tumor (KRT19 and CDH1) and stroma (FAP and VCAN) markers. B Cell type signature scores as determined by xCell. Wilcox p-values with (*) indicate statistically significant differential expression (p < 0.0001) between ET and ES

Back to article page

Clinical Proteomics

ISSN: 1559-0275